Trilogy Capital’s MetLife MET Stock Holding History
Bought
Maintained
Sold
Other funds holding MET
Trilogy Capital's MET Position: Q3 2026 in Review
Trilogy Capital reduced its MetLife (MET) stake by 0.01% in Q3 2026, selling an estimated $572 and leaving 41,699 shares worth $3.93M. The position accounts for 0.15% of the portfolio, ranked #111.
Trilogy Capital first reported a position in MET in Q1 2018 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold MET as of Q3 2026.
- Trilogy Capital held 41,699 shares of MetLife worth $3.93M as of Q3 2026.
- Trilogy Capital sold 6 MetLife shares in Q3 2026, an estimated $572.
- MetLife made up 0.15% of Trilogy Capital's portfolio in Q3 2026, its #111 holding.
- Trilogy Capital first reported a position in MetLife in Q1 2018 and has held it in 7 quarters since.
- 382 funds tracked by Wall St. Rank held MetLife as of Q3 2026.
Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.